Entia is a medical technology company that specializes in improving access to blood test.
Entia has raised €39M across 3 funding rounds from 4 investors, most recently a Series A round in Jul 2023. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2023-07-27 | Series A | €18M | BGF,Parkwalk | View deal → |
| 2021-10-11 | Other | €10M | BGF,Parkwalk Advisors,Sussex Place Ventures | View deal → |
| 2021-10-08 | Other | €10M | BGF,Parkwalk Advisors,Sussex Place Ventures | View deal → |
